FDA Inspection 1119686 — Women's Care Fertility & Reproductive Medicine, Atrium Health-Navicent

Women's Care Fertility & Reproductive Medicine, Atrium Health-Navicent — FEI 3004513862

The FDA completed an inspection of Women's Care Fertility & Reproductive Medicine, Atrium Health-Navicent on January 7, 2020 in Macon, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 7, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Macon, GA (United States)